U.S. Food and Drug Administration (FDA) news and information

Dr. Paul Offit, the chief of the infectious diseases division of Children's Hospital of Philadelphia, skewered the mega-vitamin industry in an article in the Sunday New York Times.
FULL STORY »

Tim Weaver, an 18-year-old college student who lives in Naperville, Ill., is one of the estimated 30,000 people in the U.S. who rely on intravenous nutrition products to keep them alive.
FULL STORY »

Federal health officials say they have found bacteria and fungus in drug vials from a Tennessee specialty pharmacy that recalled all of its injectable medicines last month.
FULL STORY »

Federal health experts are recommending changes to safety restrictions on Avandia in light of an analysis suggesting the drug may not raise the risk of heart attack as much as previously thought.
FULL STORY »

Three years ago, in one of the more notable drug-safety scandals in recent history, the diabetes drug Avandia was all but banned from use in the U.S. after researchers found that thousands of people had heart problems after taking it. Today, it is a drug of last resort for people with diabetes who...
FULL STORY »

Now that a majority of healthcare providers have installed electronic health-record systems, the federal government is inching closer to adopting a regulatory and patient-safety framework for computerized healthcare devices.
FULL STORY »

When Dr. Michael Edmond learned that the Food and Drug Administration had tightened its regulations governing fecal transplants, he promptly canceled 10 scheduled appointments for the procedure.
FULL STORY »

An iPhone application that lets users check levels of blood, protein and other substances in their urine is the first target of U.S. regulators seeking boundaries in a burgeoning industry for medical diagnosis on-the-go.
FULL STORY »

A senior Senate Democrat aims to expedite legislation that would establish both a track-and-trace system for drugs and a new regulatory framework for compounding pharmacies.
FULL STORY »

Patrick Lukulay faced a daunting task this month when he stepped off a plane in Accra, Ghana. Local clinics were reporting that oxytocin, a drug used to stop hemorrhaging after childbirth, was no longer working.
FULL STORY »